Tradestie Institutional Equity Comparison Engine

RARE vs XNCR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XNCR Overall Edge

XNCR Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xencor, Inc. (XNCR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while RARE counters with relative strength in Valuation. Fundamentally, RARE trades at 11.2x Forward P/E with -59.9% operating margin (+8.1% YoY revenue) versus XNCR at 68.0x Forward P/E and -72.7% operating margin (+454.9% YoY). In options structure, RARE sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro) against XNCR sits in BREAKOUT (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RARE
RARE 11.2x vs XNCR 68.0x Fwd P/E
Growth & Margin Winner XNCR
Op Margin -59.9% vs -72.7% ยท YoY +8.1% vs +454.9%
Momentum & Technical Winner XNCR
1Y -51.5% vs +154.5% ยท 52W Pos 12% vs 84%
Options & Structure Winner XNCR
BREAKDOWN (38th %ile IV) vs BREAKOUT (10th %ile IV)
RARE NASDAQ
Ultragenyx Pharmaceutical Inc.
Pharmaceutical Preparations
$15.96
-0.78% 1D
Market Cap $1.7B
1M Return +9.73%
1Y Return -51.5%
Forward P/E 11.2x
Unified AI Score
43.8 / 100 HOLD
Tech 36.0 Fund 53.0 Flow 68.0 Mom 56.0
XNCR NASDAQ
Xencor, Inc.
Pharmaceutical Preparations
$35.61
-3.99% 1D
Market Cap $2.9B
1M Return +55.84%
1Y Return +154.54%
Forward P/E 68.0x
Unified AI Score
29.6 / 100 SELL
Tech 50.0 Fund 32.0 Flow 66.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RARE -51.5% XNCR +154.54% Spread: +206.04 pp (XNCR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RARE Revenue XNCR Revenue RARE Op. Margin XNCR Op. Margin Margin Edge
FY2018 $50M $40M -721.2% -195.5% XNCR
FY2019 $100M $160M -409.0% 8.8% XNCR
FY2020 $270M $120M -121.8% -62.6% XNCR
FY2021 $350M $280M -108.6% 15.9% XNCR
FY2022 $360M $160M -178.6% -50.1% XNCR
FY2023 $430M $170M -131.1% -75.8% XNCR
FY2024 $560M $110M -95.7% -161.5% RARE
FY2025 $670M $130M -79.5% -141.4% RARE

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RARE (4) vs XNCR (6)
Institutional Metric RARE XNCR Criterion Row Winner
Market Capitalization Scale $1.7B $2.9B Larger Scale XNCR
Trailing P/E Ratio Valuation N/M 68.0x Lower Multiple XNCR
Forward P/E Ratio Valuation 11.2x 68.0x Lower Multiple RARE
Revenue Growth (YoY) Growth +8.1% +454.9% Higher Growth XNCR
Operating Margin (TTM) Profitability -59.9% -72.7% Higher Margin RARE
Net Profit Margin Profitability -71.8% -58.8% Higher Margin XNCR
Return on Equity (ROE) Capital Efficiency -608.5% -19.9% Higher ROE XNCR
52-Week Range Position Momentum 12% ($13โ€“$40) 84% ($10โ€“$41) Stronger Trend XNCR
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 57% Vol 1.21ฮฒ ยท 87% Vol Lower Realized Risk RARE
Unified Institutional Score Composite Signal 43.8 / 100 (HOLD) 29.6 / 100 (SELL) Higher Composite RARE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RARE vs XNCR Buy Guide
RARE BREAKDOWN
93d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RARE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XNCR BREAKOUT
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live XNCR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RARE nor XNCR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.